Elisabeth Schultz

Elisabeth (Liz) Schultz is a seasoned professional in commercial strategy and market access with extensive experience in the pharmaceutical industry. Currently serving as Chief Commercial Officer for EVERSANA™ COMPLETE Commercialization, Elisabeth has previously held the position of Vice President of Market Access and Patient Services at the same company. Prior experience includes roles as Director of Market Access Marketing at Sunovion Pharmaceuticals, Oncology Market Access Marketing Director at Eli Lilly and Company, and Director of Global Customer and Business Insights at Merck. Additionally, Elisabeth held the role of Director of Analytics and Insights at VMS BioMarketing, showcasing a strong background in analytics and strategic marketing within the oncology and broader pharmaceutical markets.